Bora Pharmaceuticals Co., Ltd. (TWSE: 6472)
Health Care · Pharmaceuticals · TW
NT$421.00
+0.12% today · -35.1% 1Y
Bora Pharmaceuticals Co., Ltd. (TWSE: 6472) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.68B and employs 2,255 people.
Over the last twelve months the share price has lost 35.1%, trading between 330.50 and 667.00.
Tweenvest scores Bora Pharmaceuticals Co., Ltd. across four factors: quality 61/100, value 53/100, growth 100/100, dividend 40/100. Its strongest factor is growth.
6472 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.68B
- Revenue (TTM)
- $614.73M
- P/E
- 45.31
- EPS
- 7.84
- Dividend yield
- 2.38%
- Beta (5Y)
- 0.44
- 52-week high
- NT$667.00
- 52-week low
- NT$330.50
- Avg volume (3M)
- —
- Shares outstanding
- 127.29M
- Employees
- 2,255
- Next earnings
- —
About Bora Pharmaceuticals Co., Ltd.
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
- ISIN
- TW0006472004
- Founded
- 2007
- Listed since
- Dec 11, 2023
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Shyndec Pharmaceutical Co., Ltd.SHSE: 600420 | $1.70B | CN¥8.51 | +1.43% |
| Faes Farma, S.A.BME: FAE | $1.69B | €4.85 | +2.11% |
| Alivus Life Sciences LimitedNSEI: ALIVUS | $1.68B | Rs1,326.30 | -3.49% |
| Eris Lifesciences LimitedNSEI: ERIS | $1.68B | Rs1,170.70 | -1.61% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd.SHSE: 600572 | $1.67B | CN¥4.41 | +2.32% |
| Henan Lingrui Pharmaceutical Co., Ltd.SHSE: 600285 | $1.66B | CN¥19.66 | +3.04% |
| Hanall Biopharma Co., Ltd.KOSE: A009420 | $1.66B | ₩44,000.00 | -4.56% |
| Ocular Therapeutix, Inc.NasdaqGM: OCUL | $1.66B | $7.54 | +0.40% |
Figures last refreshed Oct 11, 2026.